Current Medical and Surgical Treatments for Benign Prostatic Hyperplasia An Issue of Urologic Clinics of North America

In this issue of <i>Urologic Clinics of North America</i>, guest editor Dr. Steven A. Kaplan brings his considerable expertise to the topic of <b>Current Medical and Surgical Treatments for Benign Prostatic Hyperplasia</b>. Top experts explore evidence-based approaches, novel techniques, and outcomes that provide a holistic understanding of BPH management, sharing their clinical experience while also looking forward at how genetics and AI can impact BPH patient outcomes.<ul><li>Contains <b>14 relevant, practice-oriented topics,</b> including do genetics predict BPH?; AI in BPH; what’s new in the AUA guidelines for BPH?; UroLift, Rezum, and iTIND for BPH; medical therapy for BPH: benefits and harms; and much more</li><li>Provides in-depth <b>clinical reviews on medical and surgical treatments for benign prostatic hyperplasia</b>, offering actionable insights for clinical practice</li><li>Presents the <b>latest information on this timely, focused topic</b> under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews</li></ul>